跳至主要内容
临床试验/NCT00159536
NCT00159536已完成3 期

Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome (PCOS)

Norwegian University of Science and Technology10 个研究点 分布在 1 个国家目标入组 257 人开始时间: 2005年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
257
试验地点
10
主要终点
Preterm delivery

研究概览

简要总结

To investigate the effect of metformin on pregnancy complications and pregnancy outcome in the II. and III. trimester of pregnancy in women with polycystic ovary syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-45 years,
  • PCOS diagnosis according to Rotterdam criteria
  • single, viable, ultrasound verified fetus
  • if metformin was used at conception and early pregnancy, at least 7 days of "wash out"

排除标准

  • known liver disease or ALAT > 90 nmol/L
  • known renal disease or creatinine > 110 micromol/L
  • diabetes mellitus
  • alcohol or drug abuse
  • peroral steroid treatment
  • cimetidine, anticoagulant or erythromycin treatment at time of inclusion
  • not suitable for other reasons

研究组 & 干预措施

Metformin

Experimental

Metformin 1000mg x 2 daily

干预措施: Metformin (Drug)

placebo

Placebo Comparator

Placebo x 2 daily

干预措施: Placebo (Drug)

结局指标

主要结局

Preterm delivery

时间窗: up to delivery

pre-eclampsia

时间窗: up to delivery

Gestational diabetes

时间窗: up to delivery

incidence of metabolic syndrome and neurophysiologic parameters in offspring

时间窗: Within 18 years

次要结局

  • Snoring and sleep quality(up to delivery)
  • blood pressure change(up to delivery)
  • Incident of instrumental deliveries(at delivery)
  • Breastfeeding(One year post partum)
  • weight change(up to delivery)
  • emesis and hyperemesis(up to delivery)
  • Hormone levels in mother and offspring(up to delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验